In fact, product liability lawsuits alleging patient injuries have been filed overwhelmingly against pharmaceutical giants Eli Lilly and Novo Nordisk, which manufacture name-brand weight loss drugs, court data shows
tirzepatides is approximately 5 days
The approved Rybelsus dose range was set for glycaemic management, not for obesity pharmacotherapy
The CREDENCE, DAPA-CKD, and EMPA-KIDNEY trials showed that canagliflozin, dapagliflozin, and empagliflozin, respectively, are associated with a reduction in the composite outcome of death from renal or CV causes, end-stage renal disease, or worsening of serum creatinine or eGFR [[68-70]
The Ozempic Lawsuit focuses on claims that the diabetes and weight loss medication Ozempic has caused severe gastrointestinal side effects, including gastroparesis, nausea, and vomiting
Elina A